Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combining Dexmedetomidine and Ketamine in Intensive Care Sedation
NCT04096768Phase 3Unknown
- Sponsor
- LAU Medical Center-Rizk Hospital
- Start
- Sep 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in sedation, sponsored by LAU Medical Center-Rizk Hospital. Status: unknown.
02
Drugs
ketamine
03
Conditions
sedation
Beyond the preview
Go deeper on NCT04096768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04096768.